Supriya Lifesciences made a gap up (episodic pivot) on 8th Feb due to its blockbuster earnings, intresting part is even in the carnage of Smallcap & Midcaps the gap has been sustained continuously for 3 consecutive days, and never did it break the low of the EP candle. This shows strength in the scrip and I believe in the coming days once the market recovers, this scrip will move easily towards 400, 440 zone.
Stoploss 312
DISCLAIMER*
This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.